Combined discrete-event simulation and ant colony optimisation approach for selecting optimal screening policies for diabetic retinopathy

被引:28
作者
Brailsford S.C. [1 ]
Gutjahr W.J. [2 ]
Rauner M.S. [3 ]
Zeppelzauer W. [3 ]
机构
[1] School of Management, University of Southampton
[2] Department of Statistics and Decision Support Systems, University of Vienna, 1010 Vienna
[3] School of Business and Economics, University of Vienna, 1210 Vienna
关键词
Ant colony optimisation; Cost-effectiveness analysis; Decision-support system; Discrete event simulation; Screening for diabetic retinopathy;
D O I
10.1007/s10287-006-0008-x
中图分类号
学科分类号
摘要
In this paper we present the first application to a healthcare problem of discrete-event simulation (DES) embedded in an ant colony optimisation (ACO) model. We are concerned with choosing optimal screening policies for retinopathy, a sight-threatening complication of diabetes. The early signs of retinopathy can be detected by screening before the patient is aware of symptoms, and blindness prevented by laser treatment. In this paper we describe the methodology used to combine the purpose-written DES model with the ACO algorithm. We simulate the effects of different screening strategies on a population of diabetic patients, and compare them in terms of two objective functions: Min C/E, cost-effectiveness (minimum incremental cost per year of sight saved, compared with a no-screening baseline) and Max E, maximum effectiveness (years of sight saved). We describe how ACO is used to optimise these two objectives, and discuss the issues involved in optimising stochastic variables. We present results for a range of different assumptions and scenarios about the format of screening programmes, using realistic data, and make policy recommendations on the basis of our findings. © Springer 2006.
引用
收藏
页码:59 / 83
页数:24
相关论文
共 40 条
[1]  
Brailsford S.C., Davies R., Screening for Diabetic Retinopathy, (2001)
[2]  
Brailsford S.C., Davies R., Canning C., Roderick P.J., Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes, Health Care Manage Sci, 1, pp. 115-124, (1998)
[3]  
Photocoagulation in treatment of diabetic maculopathy, The Lancet, 2, 7945, pp. 1110-1113, (1975)
[4]  
Photocoagulation for proliferative diabetic retinopathy: A randomised controlled trial using the xenon-arc, Diabetologia, 26, pp. 109-115, (1984)
[5]  
Brown M.B., Brown G.C., Sharma S., Shah G., Utility values and diabetic retinopathy, Am J Ophthalmol, 128, pp. 324-330, (1999)
[6]  
Cooper K., Davies R., Roderick P., Chase D., Raftery J., The development of a simulation model of the treatment of coronary heart disease, Health Care Manage Sci, 5, pp. 259-267, (2002)
[7]  
Crijns H., Casparie A.F., Hendrikse F., Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy, Int J Technol Assess Health Care, 15, pp. 198-206, (1999)
[8]  
Davies R., Brailsford S.C., Screening for diabetic retinopathy, Handbook of OR/MS Applications in Health Care, pp. 493-518, (2004)
[9]  
Davies R., Davies H.T.O., Modelling patient flows and resource provision in health systems, Omega Int J Manage Sci, 22, pp. 123-131, (1994)
[10]  
Davies H.T.O., Davies R., Simulating health systems: Modelling problems and software solutions, Eur J Oper Res, 87, pp. 35-44, (1995)